Skip to content

Press Releases

Every day, more lives are transformed all over the world – one healthy habit at a time. Read the latest about how Medifast and the OPTAVIA® movement is impacting people’s lives.

New Products and Programs Drive Medifast Revenues to $12 Million for 2002, Up 140%; New Minestrone Soup and French Vanilla Berry Oatmeal to be Launched in January!
PRNewswire-FirstCall
OWINGS MILLS, Md.

Bradley T. MacDonald, Chairman of the Board announces that, "Medifast has exceeded forecast by 60% and increased revenues in 2002 by 140%, the most annual revenues since 1993." The successful introduction of the Medifast (BULLETIN BOARD: MDFT) Plus lines for Diabetics, Joint Health, Women's Health, and Appetite Suppression supported by an extensive national advertising campaign has significantly expanded the Company's patient and medical practitioner base.

During the January/February time frame of 2003, the Company will feature Coach Dick Vitale proclaiming "You Lose & You Win with Medifast Programs and Products!" The campaign will feature print ads with over 540 million impressions. Most Americans will see or hear Medifast Ads at least 2 times during the first two months of 2003. These ads will offer customers incentives to join the Medifast program supported by over 15,000 physicians since 1983. Visit www.medifastdiet.com in the first quarter to view a message from Coach Dick Vitale and a new and improved website designed to make ordering easier for customers.

In January, the company is pleased to announce the launch of Medifast Minestrone Soup and French Vanilla Berry Oatmeal that joins the popular Apple Cinnamon Oatmeal and Chicken Noodle Soup, which are complete meal replacements. Medifast now has over 50 different medical meal replacement products in its line up which helps patients and customers comply with their diet regimen. The Company will also offer the entire product line in convenient new packaging with a fresh and innovative new look by late January. On December 4, 2002, the American Exchange sent its comments letter to the company on its application filed in November. The Company is responding to its requests, and awaits the final disposition of the application and the formal response.

This release contains forward-looking statements, which may involve known, and unknown risks, uncertainties and other factors that may cause Medifast's actual results and performance in future periods to be materially different from any future results or performance suggested by these statements. Medifast cautions investors not to place undue reliance on forward-looking statements, which speak only to management's expectation on this date.

MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X67753709

SOURCE: Medifast, Inc.

CONTACT: Bradley T. MacDonald, Chairman & Chief Executive Officer,
Medifast, Inc., +1-410-581-8042, ext. 231